Literature DB >> 24718507

[Malignant nail tumors].

E Haneke1.   

Abstract

Because of the large number of different tissues making up the distal phalanx of fingers and toes, a large variety of malignant tumors can be found in and around the nail apparatus. Bowen disease is probably the most frequent nail malignancy. It is usually seen as a verrucous plaque of the nail fold and nail bed in persons above the age of 40 years. It slowly grows over a period of years or even decades before degenerating to an invasive squamous cell carcinoma. The latter may also occur primarily often as a weeping onycholysis. The next most frequent nail malignancy is ungual melanoma. Those arising from the matrix are usually pigmented and often start with a longitudinal melanonychia whereas those originating from the nail bed remain amelanotic, are often nodular and mistaken for an ingrown nail in an elderly person. The treatment of choice for in situ and early invasive subungual melanomas is generous extirpation of the nail apparatus whereas distal amputation is only indicated for advanced melanomas. In addition to these frequent nail malignancies, nail-specific carcinomas, malignant vascular and osseous tumors, other sarcomas, nail involvement in malignant systemic disorders and metastases may occur. In most cases, they cannot be diagnosed accurately on clinical grounds. Therefore, a high degree of suspicion is necessary in all isolated or single-digit proliferations that do not respond to conservative treatment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24718507     DOI: 10.1007/s00105-013-2705-z

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  74 in total

1.  Ungueotropic T-cell lymphoma.

Authors:  Elise Harland; Stéphane Dalle; Brigitte Balme; Charles Dumontet; Luc Thomas
Journal:  Arch Dermatol       Date:  2006-08

2.  Cornu cutaneum-like HPV 45 positive subungual squamous cell carcinoma.

Authors:  Michael Max Sachse; Jürgen Schmoll; Gunnar Wagner
Journal:  J Dtsch Dermatol Ges       Date:  2011-03       Impact factor: 5.584

3.  Nail biopsy for melanonychia.

Authors:  Michael D Lee; Tatayna Humphreys
Journal:  Skinmed       Date:  2012 Sep-Oct

4.  Subungual Bowen disease revealed by longitudinal melanonychia.

Authors:  Tomoko Saito; Hiroshi Uchi; Yoichi Moroi; Hiromaro Kiryu; Masutaka Furue
Journal:  J Am Acad Dermatol       Date:  2012-11       Impact factor: 11.527

5.  Aggressive Digital Papillary Adenocarcinoma in a 15-year-old Female.

Authors:  Megan K Bazil; Robert M Henshaw; Alice Werner; Eric J Lowe
Journal:  J Pediatr Hematol Oncol       Date:  2006-08       Impact factor: 1.289

6.  The presence of mucosal human papillomavirus in Bowen's disease of the hands.

Authors:  T Mitsuishi; T Sata; T Matsukura; T Iwasaki; M Kawashima
Journal:  Cancer       Date:  1997-05-15       Impact factor: 6.860

7.  Periungual porocarcinoma.

Authors:  L Requena; M Sánchez; A Aguilar; P Ambrojo; E Sánchez Yus
Journal:  Dermatologica       Date:  1990

Review 8.  Cutaneous malignancy and human immunodeficiency virus disease.

Authors:  Karl Wilkins; Ryan Turner; Jacqueline C Dolev; Philip E LeBoit; Timothy G Berger; Toby A Maurer
Journal:  J Am Acad Dermatol       Date:  2006-02       Impact factor: 11.527

9.  Periungual eccrine porocarcinoma.

Authors:  J van Gorp; S C van der Putte
Journal:  Dermatology       Date:  1993       Impact factor: 5.366

10.  Melanoma and squamous cell carcinoma on different nails of the same hand.

Authors:  Michael Harwood; Gladys H Telang; Leslie Robinson-Bostom; Nathaniel Jellinek
Journal:  J Am Acad Dermatol       Date:  2008-02       Impact factor: 11.527

View more
  2 in total

1.  [Allways an important subject : Diagnosis and treatment of nail diseases].

Authors:  Christoph R Löser
Journal:  Hautarzt       Date:  2018-09       Impact factor: 0.751

Review 2.  The Diagnosis and Treatment of Nail Disorders.

Authors:  Uwe Wollina; Pietro Nenoff; Gunter Haroske; Holger A Haenssle
Journal:  Dtsch Arztebl Int       Date:  2016-07-25       Impact factor: 5.594

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.